ir.revamedical.com
Investor Relations | REVA MedicalView REVA Medical's Investor Relations. Contact us at +1-858-966-3000 or info@revamedical.com to learn more.
http://ir.revamedical.com/
View REVA Medical's Investor Relations. Contact us at +1-858-966-3000 or info@revamedical.com to learn more.
http://ir.revamedical.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.4 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
12
SITE IP
23.213.123.49
LOAD TIME
0.354 sec
SCORE
6.2
Investor Relations | REVA Medical | ir.revamedical.com Reviews
https://ir.revamedical.com
View REVA Medical's Investor Relations. Contact us at +1-858-966-3000 or info@revamedical.com to learn more.
ir.revamedical.com
REVA Medical, Inc. - Analyst Coverage / Reva Medical
http://ir.revamedical.com/analysts.cfm
Skip to primary content. Skip to this section navigation. Skip to secondary content. Share Price and Information. Phone: 61 2 8224 2849. Phone: 61 2 9043 7904. Share Price and Information. REVA Medical, Inc.
REVA Medical, Inc. - Investor Relations / Reva Medical
http://ir.revamedical.com/index.cfm
Skip to primary content. Skip to this section navigation. Skip to secondary content. Share Price and Information. View all ». Aug 10, 2016. REVA to Hold Briefing Call on Q2 2016 Financial Results. Aug 10, 2016. Notice of Briefing Call. Share Price and Information. REVA Medical, Inc.
REVA Medical, Inc. - Events & Presentations / Reva Medical
http://ir.revamedical.com/events.cfm
Skip to primary content. Skip to this section navigation. Skip to secondary content. Share Price and Information. Details on upcoming events are not yet available. Aug 16, 2016. REVA Medical 2016 Second Quarter Update Call. To access the call by telephone:. Dial 1800 005 989 within Australia. Dial 1-877-312-5413 within the United States and Canada. If you are asked to provide an access code, please spell out the word REVA to the operator and you will be connected promptly. May 25, 2016. May 17, 2016.
REVA Medical, Inc. - Events & Presentations / Reva Medical
http://ir.revamedical.com/eventdetail.cfm?EventID=163681
Skip to primary content. Skip to this section navigation. Skip to secondary content. Share Price and Information. REVA Medical 2015 Second Quarter Update Call. Aug 12, 2015. The call may be accessed within the United States and Canada by dialing 1-877-312-5413 five minutes prior to the scheduled start time. Callers in Australia my access the call by dialing (02) 8223 9773. If you are asked to provide an access code, please spell out the word REVA and you will be connected promptly. Back to previous page.
REVA Medical, Inc. - Management / Reva Medical
http://ir.revamedical.com/management.cfm
Skip to primary content. Skip to this section navigation. Skip to secondary content. Share Price and Information. REVA Medical's talented executive management team has extensive depth and breadth of experience working with start-up and development companies in the pharmaceutical, biotechnology and medical device fields. CFO and Corporate Secretary. Sr Vice President, Clinical and Regulatory Affairs. Sr Vice President, Product Development. Sr Vice President, Operations. Share Price and Information.
TOTAL PAGES IN THIS WEBSITE
18
Repros Therapeutics Inc. - Investor Relations
Board of Directors and Management. Events, Presentations and Webcasts. Repros in the News. Events, Presentations and Webcasts. Repros in the News. 12:34 PM ET on Jan 12, 2017. Delayed at least 20 minutes. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Repros Therapeutics Inc.'s financial performance into perspective. Dec 19, 2016. Dec 12, 2016. View all releases ». 2408 Timberloch Place, B-7.
Investor Relations - RGP
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.
Investor Relations - RGP
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.
Retrophin, Inc. - Investor Relations
Retrophin, Inc. (NASDAQ: RTRX) is a publicly-traded, San Diego-based biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options. The Company is currently focused on several catastrophic diseases affecting children, including Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), and...
Reunert Limited Integrated Annual report 2013 | Home
2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.
Investor Relations | REVA Medical
Skip to main navigation. REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead product, the Fantom bioresorbable scaffold, received European CE Mark on April 3, 2017 for the treatment of coronary artery disease. ASX RVA.AX (CDI). Mar 30, 2018 12:26 AM EDT. 10 CDIs equivalent to one share of common stock. March 27, 2018. REVA Announces First Implant of Fantom Encore in Switzerland.
INVESTOR RELATIONS | Rex Energy Corporation
Skip to main navigation. Owner and Leasing Relations. Feb 06, 2018. Rex Energy Announces Fourth Quarter and Full Year 2017 Production and Estimated Price Realizations and Provides Operational Update. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer. 7:18 PM EDT on Mar 29, 2018. Mar 14, 2018. Rex Energy Announces Sale of Non-Operated Oil and Gas Interests in Westmoreland, Centre and Clearfield Counties. Feb 06, 2018. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer.
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
1.76精品地图补丁_传奇1.80装备补丁下载_热血传奇1.85装备补丁_传奇1.80合击
Http:/ www.zhjcfsb.com/cq/html498/ 1.80雷霆终极. 2009-2015 www.ir.rfot.pw.
Investor Relations - RGP
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.
Rheinmetall Group - Investor Relations
Rheinmetall AG Investor Relations. Der Technologiekonzern für Sicherheit und Mobilität. Modernen Gesellschaft: Rheinmetall Defence ist als führendes europäisches Systemhaus für Heerestechnik ein zuverlässiger Partner der Streitkräfte Deutschlands, der NATO und befreundeter Nationen. Das Automotive-Segment nimmt mit den Produkten seiner bekannten Marken Kolbenschmidt, Pierburg und Motorservice weltweite Spitzenpositionen als Automobilzulieferer für Systeme und Module rund um den Motor ein. Kontinuität an ...
SOCIAL ENGAGEMENT